Comprehensive genomic analysis of PKHD1 mutations in ARPKD cohorts.

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMC 1736033)

Published in J Med Genet on April 01, 2005

Authors

A M Sharp, L M Messiaen, G Page, C Antignac, M-C Gubler, L F Onuchic, S Somlo, G G Germino, L M Guay-Woodford

Articles citing this

Intragenic motifs regulate the transcriptional complexity of Pkhd1/PKHD1. J Mol Med (Berl) (2014) 1.56

Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. J Am Soc Nephrol (2010) 1.52

Polyductin undergoes notch-like processing and regulated release from primary cilia. Hum Mol Genet (2007) 1.44

Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol Genet Metab (2007) 1.31

Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference. J Pediatr (2006) 1.26

Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1. Am J Pathol (2008) 1.17

Autosomal recessive polycystic kidney disease: a hepatorenal fibrocystic disorder with pleiotropic effects. Pediatrics (2014) 1.14

Polycystin-2 expression is regulated by a PC2-binding domain in the intracellular portion of fibrocystin. J Biol Chem (2008) 1.10

PKHD1 sequence variations in 78 children and adults with autosomal recessive polycystic kidney disease and congenital hepatic fibrosis. Mol Genet Metab (2009) 1.07

Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol (2010) 0.99

Analysis of missense variants in the PKHD1-gene in patients with autosomal recessive polycystic kidney disease (ARPKD). Hum Genet (2005) 0.90

Polycystic kidney disease: inheritance, pathophysiology, prognosis, and treatment. Int J Nephrol Renovasc Dis (2010) 0.85

Transcriptional complexity in autosomal recessive polycystic kidney disease. Clin J Am Soc Nephrol (2014) 0.82

Whole exome sequencing identifies recessive PKHD1 mutations in a Chinese twin family with Caroli disease. PLoS One (2014) 0.79

Molecular genetic analysis of PKHD1 by next-generation sequencing in Czech families with autosomal recessive polycystic kidney disease. BMC Med Genet (2015) 0.79

Cost-effective PKHD1 genetic testing for autosomal recessive polycystic kidney disease. Pediatr Nephrol (2013) 0.78

Clinical and genetic characterization of a founder PKHD1 mutation in Afrikaners with ARPKD. Pediatr Nephrol (2014) 0.78

Genetic contribution and associated pathophysiology in end-stage renal disease. Appl Clin Genet (2010) 0.77

Posterior reversible encephalopathy syndrome in a uremic patient with autosomal recessive polycystic kidney disease. CEN Case Rep (2015) 0.75

Autosomal recessive polycystic kidney disease: the importance of autopsy of suspected cases and genetic counselling. BMJ Case Rep (2010) 0.75

Expanding the mutation spectrum in 130 probands with ARPKD: identification of 62 novel PKHD1 mutations by sanger sequencing and MLPA analysis. J Hum Genet (2016) 0.75

Targeted exome sequencing resolves allelic and the genetic heterogeneity in the genetic diagnosis of nephronophthisis-related ciliopathy. Exp Mol Med (2016) 0.75

Nitric oxide synthase and polycystic kidney disease. J Nephropharmacol (2015) 0.75

Pathways, perspectives and pursuits in polycystic kidney disease. J Nephropharmacol (2015) 0.75

NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology. Sci Rep (2017) 0.75

Articles by these authors

NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 7.98

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum (1999) 6.39

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature (2001) 4.28

Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell (1998) 3.84

PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat Genet (1997) 3.58

The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I. Cell (1996) 3.49

A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet (1998) 3.24

Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet (2001) 2.87

Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem (1999) 2.74

X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol (2000) 2.71

Getting a foothold in nephrotic syndrome. Nat Genet (2000) 2.68

Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int (2007) 2.64

The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.26

Cardiac defects and renal failure in mice with targeted mutations in Pkd2. Nat Genet (2000) 2.24

Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet (1994) 2.12

Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell (2000) 1.94

Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics (1995) 1.86

Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet (1998) 1.85

Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J (2001) 1.83

Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11). J Med Genet (2009) 1.82

Autosomal dominant polycystic kidney disease: localization of the second gene to chromosome 4q13-q23. Genomics (1993) 1.77

Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in inherited smooth muscle tumors. Science (1993) 1.77

Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A (1997) 1.75

Characterization of the NPHP1 locus: mutational mechanism involved in deletions in familial juvenile nephronophthisis. Am J Hum Genet (2000) 1.73

Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66

News from the interface: the molecular structures of triacylglyceride lipases. Trends Biochem Sci (1993) 1.64

Nerve growth cones isolated from fetal rat brain: subcellular fractionation and characterization. Cell (1983) 1.62

Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease. Mol Cell (1998) 1.61

Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol (2001) 1.56

A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci III (1991) 1.56

Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol (2001) 1.55

Secondary and tertiary structure modeling reveals effects of novel mutations in polycystic liver disease genes PRKCSH and SEC63. Clin Genet (2010) 1.55

Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. J Am Soc Nephrol (2000) 1.47

Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet (2001) 1.47

Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome. J Am Soc Nephrol (2001) 1.46

Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum Mol Genet (1999) 1.45

Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1. J Med Genet (2005) 1.45

A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis. Hum Mol Genet (1997) 1.44

Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney Int (2007) 1.44

HLA-DR4 may determine expression of actinic prurigo in British patients. J Invest Dermatol (1996) 1.44

Mutational analysis of the RPGRIP1L gene in patients with Joubert syndrome and nephronophthisis. Kidney Int (2007) 1.43

Large homozygous deletions of the 2q13 region are a major cause of juvenile nephronophthisis. Hum Mol Genet (1996) 1.42

Glomerular expression of type IV collagen chains in normal and X-linked Alport syndrome kidneys. Am J Pathol (2000) 1.37

The polycystic kidney disease protein PKD2 interacts with Hax-1, a protein associated with the actin cytoskeleton. Proc Natl Acad Sci U S A (2000) 1.36

Content validation of key features on a national examination of clinical decision-making skills. Acad Med (1995) 1.35

The targeting of cystinosin to the lysosomal membrane requires a tyrosine-based signal and a novel sorting motif. J Biol Chem (2001) 1.33

Brief report: a molecular defect in the vasopressin V2-receptor gene causing nephrogenic diabetes insipidus. N Engl J Med (1993) 1.31

Sclerosing lymphocytic lobulitis of the breast--evidence for an autoimmune pathogenesis. Histopathology (1991) 1.30

A second genetic locus for autosomal dominant polycystic kidney disease. Lancet (1988) 1.29

Molecular characterization of CTNS deletions in nephropathic cystinosis: development of a PCR-based detection assay. Am J Hum Genet (1999) 1.28

Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet (1995) 1.28

Vascular expression of polycystin-2. J Am Soc Nephrol (2001) 1.28

The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: implications for genetic counseling. Am J Hum Genet (1995) 1.27

Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease. J Am Soc Nephrol (1999) 1.26

Regional localization of the autosomal dominant polycystic kidney disease locus. Genomics (1988) 1.26

Autosomal dominant distal renal tubular acidosis is associated in three families with heterozygosity for the R589H mutation in the AE1 (band 3) Cl-/HCO3- exchanger. J Biol Chem (1998) 1.25

Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. Am J Hum Genet (2000) 1.24

Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet (1996) 1.20

Adequate clinical control of congenital nephrotic syndrome by enalapril. Pediatr Nephrol (1998) 1.19

Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet (2005) 1.18

An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection. Hum Mol Genet (1997) 1.17

Molecular genetics and mechanism of autosomal dominant polycystic kidney disease. Mol Genet Metab (2000) 1.17

Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int (1995) 1.16

"Mistakes happen": somatic mutation and disease. Am J Hum Genet (1997) 1.15

Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B. Virology (1991) 1.15

Gene conversion is a likely cause of mutation in PKD1. Hum Mol Genet (1998) 1.15

Congenital nephrotic syndrome of the Finnish type: linkage to the locus in a non-Finnish population. Pediatr Nephrol (1996) 1.14

Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet (1998) 1.13

The gene for autosomal dominant polycystic kidney disease lies in a 750-kb CpG-rich region. Genomics (1992) 1.12

Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol (2001) 1.12

Linkage disequilibrium in the region of the autosomal dominant polycystic kidney disease gene (PKD1). Am J Hum Genet (1994) 1.11

Interleukin-17 increases the effects of IL-1 beta on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J Neuroimmunol (2003) 1.10

Genetic disorders of renal electrolyte transport. N Engl J Med (1999) 1.10

PAX2 mutations in renal-coloboma syndrome: mutational hotspot and germline mosaicism. Eur J Hum Genet (2000) 1.10

Novel molecular variants of the Na-K-2Cl cotransporter gene are responsible for antenatal Bartter syndrome. Am J Hum Genet (1998) 1.09

In vivo interaction of the adapter protein CD2-associated protein with the type 2 polycystic kidney disease protein, polycystin-2. J Biol Chem (2000) 1.08

Telomere-related sequences at interstitial sites in the human genome. Genomics (1990) 1.07

Complement C3 activation in cyst fluid and urine from autosomal dominant polycystic kidney disease patients. J Intern Med (2014) 1.07

Mapping a gene (SRN1) to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet (1995) 1.07

Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol (1998) 1.06

Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease. Am J Hum Genet (1999) 1.05

Identification of PKD2L, a human PKD2-related gene: tissue-specific expression and mapping to chromosome 10q25. Genomics (1998) 1.04

A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). Am J Hum Genet (1997) 1.04

Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet (1992) 1.03

Polycystin-2 expression is developmentally regulated. Am J Physiol (1999) 1.02

Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. Am J Kidney Dis (2001) 1.01